US Demands Up To $3.35B From Novartis In FCA Suit
By Dani Meyer · June 30, 2015, 6:26 PM EDT
The government is seeking up to $3.35 billion in a False Claims Act suit accusing Novartis Pharmaceutical Corp. of paying illegal kickbacks to pharmacies to recommend iron-reduction drug Exjade and transplant...
To view the full article, register now.